期刊文献+

血浆和肽素与急性心肌梗死患者近期预后的关系 被引量:12

Relationship of plasma Copeptin and short-term prognosis of patients with acute myocardial infarction
原文传递
导出
摘要 目的:探讨血浆和肽素和肌钙蛋白I(cTnI)在急性心肌梗死(AMI)患者中的关系及对其近期预后的预测价值。方法:选择因胸痛(发病时间<24h)入院诊断为AMI患者97例,冠状动脉造影正常者30例为对照组。采用ELISA法测定血浆和肽素浓度,采用免疫荧光定量技术测定cTnI浓度,连续测定3d和肽素和cTnI水平。记录患者住院和平均随访6个月期间的心血管事件(心血管死亡、心力衰竭、再发心绞痛或再发心肌梗死)的发生情况。结果:AMI组和肽素浓度高于对照组(17.68vs 3.51pmol/L,P<0.05);发病第1天和肽素水平高于第3天(17.68vs 6.46pmol/L,P<0.05),尤以发病0~3h升高最明显;AMI组cTnI与和肽素浓度呈负相关;发生心血管事件组和肽素水平高于未发生心血管事件组,多变量logistic逐步回归表明发病第3天和肽素水平是预测近期心血管事件的危险因素(OR=1.315,95%CI:1.171~1.475,P<0.05)。结论:和肽素与cTnI之间呈负相关,发病第3天和肽素水平是预测近期心血管事件的有效指标之一。 Objective:To explore the correlation between C-terminal portion of provasopressin(Copeptin) and cardiac troponin I(cTnI) in patients with acute myocardial infarction and the short-term prognosis value of Copeptin. Method:We selected 97 subjects who had acute myocardial infarction(AMI) with onset 24 h in our study,with follow-up average 6 months,and 30 normal coronary angiography(CAG) as control group.The plasma Copeptin were measured by enzyme-linked immunosorbent assay(ELISA);the plasma cTnI were measured by immunofluorometric assay technique.Copeptin and cTnI were measured daily for 3 days.The clinical main adverse cardiac events(MACE) including cardiac death,heart failure,myocardial infarction or recurrent angina pectoris were recorded during hospitalization and follow-up. Result:Compared with control subjects,level of Copeptin and cTnI were higher in patients with AMI(P0.05).The admission plasma levels of Copeptin in AMI were higher than the third day [(17.68 vs 6.46)pmol/L,P0.05],especially the 0~3 h plasma levels of Copeptin were more higher.Negative correlations between Copeptin and cTnI were observed by Spearman correlations analysis.In the AMI patients,Copeptin level was elevated in patients with MACE compared with patients without MACE.Multivariate logistic regression analysis revealed that the third day Copeptin level was independently associated with MACE during average 6 months(odds ratio: 1.315,95% confidence interval: 1.171~1.475,P0.05). Conclusion:There is negative correlation between the level of Copeptin and cTnI of patients with AMI.The third day plasma level of Copeptin is associated with short-term prognosis in patients with AMI.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第9期680-682,共3页 Journal of Clinical Cardiology
关键词 急性心肌梗死 肌钙蛋白I 和肽素 预后 acute myocardial infarction cardiac troponinI copeptin prognosis
  • 相关文献

参考文献7

  • 1KHAN S Q, DHILLON Q S, O'BRIEN R J, et al. C-Terminal provasopressin (Copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute MyocardialInfarctionPeptide (LAMP) Study[J]. Circulation, 2007,115 : 2103 - 2110.
  • 2REICHLIN T, HOCHHOLZER W, STELZIG C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]. J Am Coll Cardiol, 2009,54:60-68.
  • 3KELLER T, TZIKAS S, ZELLER T, et al. Copeptin improves early diagonisis of acute myocardial in- farction[J].J Am Coll Cardiol,2010,55:2096-2106.
  • 4VOORS A A, HAEHLING S, ANKER S D, et al. C- terminal provasopressin (Copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study[J]. Eur Heart J,2009,30..1187-1194.
  • 5中华医学会心血管病学分会.中华心血管病杂志编辑委员会,急性心肌梗死诊断和治疗指南.中华心血管病杂志,2001,.
  • 6王晓,聂绍平,马长生.急性心肌梗死后延迟再灌注治疗的研究进展[J].临床心血管病杂志,2010,26(8):563-565. 被引量:4
  • 7MORGENTHALER N G, STRUCK J, ALONSO C, et al. Assay for the measurement of Copeptin, a stable peptide derived from the precursor of vasopressin [J]. J Clin Chem,2006,52:112-119.

二级参考文献18

  • 1McNAMARA R L,WANG Y,HERRIN J,et al.Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2006,47:2180-2186.
  • 2KIM C B,BRAUNWALD E.Potential benefits of late reperfusion of infarcted myocardium.The open artery hypothesis[J].Circulation,1993,88(5 Pt 1):2426-2436.
  • 3ABBATE A,BUSSANI R,BIONDI-ZOCCAI G G,et al.Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction[J].Circulation,2002,106:1051-1054.
  • 4JUGDUTT B I.Ventricular remodeling after infarction and the extracellular collagen matrix:when is enough enough?[J].Circulation,2003,108:1395-1403.
  • 5NAKAGAWA M,TAKEMURA G,KANAMORI H,et al.Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling[J].Circ Res,2008,103:98-106.
  • 6ABBATE A,BIONDI-ZOCCAI G G,BALDI A,et al.The 'Open-Artery Hypothesis':New Clinical and Pathophysiologic Insights[J].Cardiology,2003,100:196-206.
  • 7DZAVIK V,BEANLANDS D S,DAVIES R F,et al.Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (《6 weeks) Q-wave acute myocardial infarction (total occlusion post-myocardial infarction intervention study[TOMIIS] -A pilot study)[J].Am J Cardiol,1994,73:856-861.
  • 8HORIE H,TAKAHASHI M,MINAI K,et al.Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty[J].Circulation,1998,98:2377-2382.
  • 9YOUSEF Z R,REDWOOD S R,BUCKNALL C A,et al.Late intervention after anterior myocardial infarction:effects on left ventricular size,function,quality of life,and exercise tolerance:Results of the Open Artery Trial (TOAT Study)[J].J Am Coll Cardiol,2002,40:869-876.
  • 10HOCHMAN J S,LAMAS G A,BULLER C E,et al.Coronary intervention for persistent occlusion after myocardial infarction[J].N Engl J Med,2006,355:2395-2407.

共引文献6

同被引文献126

  • 1闫青叶,赵玉清,袁桂莉,刘金禄,李跃,李方江.慢性心力衰竭患者血浆和肽素的水平及意义[J].中国老年学杂志,2014,34(2):302-304. 被引量:11
  • 2陆龙,崔振田.果糖二磷酸钠对室间隔缺损修补术后心肌保护作用的研究[J].临床军医杂志,2010,38(4):492-494. 被引量:6
  • 3郭萍,李成建,田玉琴.果糖二磷酸钠不良反应[J].中国误诊学杂志,2007,7(3):659-659. 被引量:4
  • 4张晓霞,韩培红.马来酸桂哌齐特的药理作用及临床应用研究[J].中国药房,2007,18(26):2060-2062. 被引量:149
  • 5CORREIA L C, ESTEVES J P. C-reactive protein and outcomes in acute coronary syndromes: a system- atic review and meta-analysis[J]. Arq Bras Cardiol, 2011,97:76-85.
  • 6MORA S, GLYNN R J, HSIA J, et al. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive pro- tein or dyslipidemia: results from the Justi{ication or the Use of Statins in Prevention: An Intervention Tri- al Evaluating Rosuvastatin (JUPITER) and meta-a- nalysis of women from primary prevention trials[J].Circulation,2010,121 : 1069-1077.
  • 7RIEZEBOS R K, LAARMAN G J, TIJSSEN J G, et al. The value of N-terminal proB-type natriuretic pep- tide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coro- nary syndromes[J]. Clin Chem Lab Med, 2011,49:1359-1365.
  • 8FROHLICH G M, SCHOCH B, SCHMID F, et al. Takotsubo cardiomyopathy has a unique cardiac bio- marker profile: NT-proBNP/myoglobin and NT- proBNP/troponin T ratios for the differential diagno- sis of acute coronary syndromes and stress induced cardiomyopathy[J]. Int J Cardiol, 2012, 154: 328- 332.
  • 9MCMURRAY J J, PFEFFER M A. Heart failure [J]. Lancet, 2005,365 : 1877- 1889.
  • 10LLOYD-JONES D M, LARSON M G, LEIP E P, et al, Lifetime risk for developing congestive heart fail- ure: the Framingham Heart Study[J]. Circulation, 2002,106 : 3068- 3072.

引证文献12

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部